EU signs outline deal for 200 million doses of Novavax Covid vaccine

The European Commission has signed a preliminary deal to buy up to 200 million doses of a promising Covid-19 vaccine from US pharmaceutical firm Novavax. The agreement depends on the Novavax vaccine being approved by the EU's regulator, the European Medicines Agency.

Making the announcement, EU health commissioner Stella Kyriakides said: "Our new agreement with Novavax expands our vaccine portfolio to include one